Lormetazepam is a benzodiazepine mainly used for the short-term treatment of severe insomnia, helping with sleep onset and maintenance, and sometimes for anxiety-related sleep issues, acting as a sedative-hypnotic by enhancing GABA in the brain. It’s prescribed for disabling insomnia or extreme distress but should be used at the lowest dose for the shortest time (typically under 4 weeks) to avoid dependence, with effects like dizziness and sedation impacting activities like driving. It is grouped under the following drug class(es): Benzodiazepines, Hypnotics and Schedule IV controlled substances. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Methyllorazepam and Loramet. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 13314.
Lormetazepam
| CAS No | 848-75-9 |
|---|---|
| Molecular Formula | C16H12Cl2N2O2 |
| Molecular Weight | 335.20 g/mol |
| Synonyms | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lormetazepam is a benzodiazepine mainly used for the short-term treatment of severe insomnia, helping with sleep onset and maintenance, and sometimes for anxiety-related sleep issues, acting as a sedative-hypnotic by enhancing GABA in the brain.
The listed CAS number is 848-75-9.
The listed molecular formula is C16H12Cl2N2O2.
The listed molecular weight is 335.20 g/mol.
7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one.
The source lists Methyllorazepam and Loramet.